Spaceflight-guided pharmacogenomics: a foundational analysis of pharmaceuticals and their responsive gene targets in the space environment
Abstract
Human spaceflight alters physiology in ways that can impact drug safety and efficacy, yet progress in this area has been hampered by a lack of integrated data. Our primary objective was to establish a Findable, Accessible, Interoperable, and Reproducible (FAIR) data curation framework by developing a novel database of pharmaceuticals used in spaceflight. This resource, compiled from publicly available literature, serves as a foundation for integrated pharmacological analysis. Using this resource, we demonstrate a data-driven framework for identifying pharmacologically-relevant, spaceflight-responsive genes by intersecting our drug catalog with available space-omics datasets. By focusing on the biological mechanisms perturbed by spaceflight, this approach provides a new avenue for pinpointing the most relevant changes within drug absorption, distribution, metabolism, and excretion (ADME) pathways. While necessarily limited by available tissue types, this work provides both the justification and a definitive starting point for spaceflight-guided pharmacogenomics. Ultimately, this establishes a foundational methodology to ensure the health and safety of future astronauts on long-duration missions to the Moon, Mars, and beyond.
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.